Donald J Santel
CIK 1293630 · CEO & President · last filed 2024-06-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$542
Companies
6
Total Filings
17
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jade Biosciences, Inc. (AVTE) Delisted | Director | — | $93.80 | — | $0 | 4 | 2024-06-07 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 0 | $11.17 | $0 | $0 | 3 | 2023-01-04 |
| SRZNW | 30,000 | $0.02 | $542 | $0 | 1 | 2021-08-13 | |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | CEO & President | 0 | — | — | $0 | 6 | 2015-05-08 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | — | — | — | $0 | 2 | 2011-07-05 |
| COTHERIX INC (CTRX) Delisted | Chief Executive Officer | 0 | — | — | $0 | 1 | 2007-01-10 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-10 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2015-01-05 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Tax (F) | −2,022 | -$49.1K | EDGAR |
| 2014-03-13 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Grant (A) | +18,500 | $0 | EDGAR |
| 2013-05-01 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-07-05 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-10-04 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-10 | COTHERIX INC (CTRX) Delisted | Disp (D) | −72,033 | -$972.4K | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.